Medicine and Dentistry
Prostate Cancer
100%
Survival Rate
92%
Patient
82%
Incidence
63%
Mortality Rate
58%
Age
43%
Cancer Specific Survival
37%
Analysis
37%
Prevalence
32%
Malignant Neoplasm
29%
Checkpoint Kinase 2
29%
Genetic Trait
29%
Bladder Cancer
29%
Cohort Effect
29%
Ureter
29%
Cancer Risk
29%
Ovarian Cancer
23%
Odds Ratio
23%
Cancer Mortality
22%
Mortality
22%
Breast Cancer
11%
Multiplex Polymerase Chain Reaction
11%
Blood Donor
11%
Gleason Score
11%
Gene
10%
Male
9%
Diagnosis
8%
Kaplan Meier Method
8%
Age Groups
5%
Bladder Cancer Diagnosis
5%
Regression Analysis
5%
Deterioration
5%
Gender
5%
Genetic Predisposition
5%
Cancer Susceptibility
5%
Fisher Exact Test
5%
Association
5%
Blood Sampling
5%
Donor
5%
Colorectal Cancer
5%
Personnel
5%
Cancer Incidence
5%
DNA
5%
Biochemistry, Genetics and Molecular Biology
Age
50%
Survival Rate
47%
Telomere Length
29%
Genetic Trait
29%
Telomere
29%
Mortality
29%
Mutation
29%
CHEK2
29%
Cancer Specific Survival
24%
Radiation
23%
Incidence
17%
Development
17%
Nested Gene
17%
Genetic Code
17%
Gleason Score
14%
Telomerase
11%
Carcinogenesis
11%
Time
11%
Prevalence
11%
Leukocytes
5%
Aging
5%
Health Status
5%
Chromosome
5%
Autosome
5%
Attention
5%
Real-Time Polymerase Chain Reaction
5%
Regulatory Mechanism
5%
Gender
5%
Telomere Shortening
5%
Morphology
5%
Motivation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
29%
Epidemiology
29%
Plant
29%
Ionizing Radiation
23%
Malignant Neoplasm
13%
Carcinogenesis
11%
Telomerase
11%
Mortality
11%
Health Status
5%
Cataract
5%
Radiation Exposure
5%
Cardiovascular Disease
5%
Ischemic Heart Disease
5%
Osteoporosis
5%
Healing
5%
Degenerative Disease
5%
Atherosclerosis
5%
DNA
5%
